Viral Fusion Protein Inhibitors [inhibitory virových fúzních proteinů]

topical
Terms

inhibitory proteinů virové fúze

Persistent link   https://www.medvik.cz/link/D065147
Definition

Drugs that are designed to block the action of VIRAL FUSION PROTEINS and prevent VIRUSES from entering the cell.

DUI
D065147 MeSH Browser
CUI
M0587614
History note
2015
Public note
2015

Allowable subheadings

AD
administration & dosage
AE
adverse effects
AN
analysis
BL
blood
CF
cerebrospinal fluid
CS
chemical synthesis
CH
chemistry
CL
classification
EC
economics
HI
history
IM
immunology
IP
isolation & purification
ME
metabolism
PK
pharmacokinetics
PD
pharmacology
PO
poisoning
RE
radiation effects
ST
standards
SD
supply & distribution
TU
therapeutic use
TO
toxicity
UR
urine

D Chemicals and Drugs
D27 Chemical Actions and Uses 374
D27.505 Pharmacologic Actions 410
D27.505.519 Molecular Mechanisms of Pharmacological Action 89
D27.505.519.124 Alkylating Agents 91
D27.505.519.143 Amylin Receptor Agonists
D27.505.519.162 Angiotensin Receptor Antagonists 224
D27.505.519.170 Antacids 162
D27.505.519.174 Antidiuretic Hormone Receptor Antagonists 28
D27.505.519.178 Antifoaming Agents 12
D27.505.519.182 Antiglycation Agents
D27.505.519.186 Antimetabolites 120
D27.505.519.217 Antioxidants 2 539
D27.505.519.241 Aversive Agents
D27.505.519.265 Bradykinin Receptor Antagonists 10
D27.505.519.270 Calcitonin Gene-Related Peptide Receptor Antagonists 78
D27.505.519.275 CCR5 Receptor Antagonists 4
D27.505.519.295 Cerumenolytic Agents 1
D27.505.519.334 Cystine Depleting Agents
D27.505.519.349 Cytochrome P-450 Enzyme Inducers 10
D27.505.519.364 Endothelin Receptor Antagonists 121
D27.505.519.374 Enzyme Activators 30
D27.505.519.389 Enzyme Inhibitors 883
D27.505.519.405 Enzyme Reactivators 16
D27.505.519.421 Fibrin Modulating Agents 2
D27.505.519.452 Heparin Antagonists 23
D27.505.519.507 Immune Checkpoint Inhibitors 380
D27.505.519.562 Membrane Transport Modulators 22
D27.505.519.593 Mitosis Modulators 3
D27.505.519.625 Neurotransmitter Agents 520
D27.505.519.656 Nitric Oxide Donors 63
D27.505.519.828 Peptidomimetics 11
D27.505.519.871 Radiopharmaceuticals 817
D27.505.519.914 Sequestering Agents 1
D27.505.519.936 Sodium-Glucose Transporter 2 Inhibitors 822
D27.505.519.947 Sphingosine 1 Phosphate Receptor Modulators 30
D27.505.519.952 Toll-Like Receptor Agonists
D27.505.519.957 Viral Fusion Protein Inhibitors
D27.505.519.957.500 HIV Fusion Inhibitors 14
D27.505.954 Therapeutic Uses 62
D27.505.954.122 Anti-Infective Agents 1 137
D27.505.954.122.388 Antiviral Agents 1 956
D27.505.954.122.388.077 Anti-Retroviral Agents 192
D27.505.954.122.388.308 Reverse Transcriptase Inhibitors 93
D27.505.954.122.388.538 Viral Fusion Protein Inhibitors
D27.505.954.122.388.538.500 HIV Fusion Inhibitors 14
D27.505.954.122.388.769 Viral Protease Inhibitors 6

Add

Narrower terms